Alterity Therapeutics ATHE
NASDAQ ATHE
$2.15 -0.24 (-10.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Long-Term Investments (2017)

Updated

Alterity Therapeutics (ATHE) posted Long-Term Investments of $120,498 for the quarter ended Dec 31, 2017.

Analysis

Alterity Therapeutics (ATHE) Long-Term Investments (2017) Analysis & Trends

As of Jun 30, 2017, Alterity Therapeutics' Long-Term Investments came in at $112,682.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 266.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 297.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.56 Bn
10 Alterity Therapeutics 37.63 Mn -45.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 122,126.44
Jun 30, 2017 115,278.21
API Access

Alterity Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ATHE&period=max&api_key=YOUR_API_KEY